Many people have heard of “regulatory affairs,” but do not know what exactly that means. In my understanding, regulatory affairs is a field where you write, review, edit and submit all kinds of documents required in the process of drug development and clinical trials. The ultimate purpose is to ...
If industry is the dark side of science, strategic marketing is the dark side of industry, or so it seems. As scientists sitting in teams with our strategic marketing colleagues, we always wondered how they came up with those projections of how much revenue a drug would have in 2025 (yes, they...
Hello! My name is Heather, and I am currently a postdoctoral fellow. As I was thinking about beginning this blog, one question kept popping into my head “What makes me qualified to give career advice?” And what I realized is that I am not any different from the scientist sitting next to you. ...
The New York Times published a graphic, the Beveridge Curve on March 6, 2013, noting that there is “A Shift Toward Higher Job Vacancy Rates.” The New York Times Source: Bureau of Labor Statistics.The Beveridge Curve compares the job vacancy rate with the unemployment rate.  ...
I recently watched Skyfall, the new James Bond film, and it made me think of spy’s. More importantly, how they die in movies (and real life). I kept thinking of From Russia with Love and Rosa Klebb who tried to kill Bond with a poisoned knife in her shoe. From poisons, I started ...
It’s the same old song---contaminated drugs from China. The news was reported by Laurie Burkitt in the Wall Street Journal on April 17, 2012. Chinese authorities halted the sale of 13 drugs, because the gelatin capsules used in manufacturing were found to have high levels of the ...
In 1925, Sinclair Lewis published Arrowsmith (a novel for which he later won a Pulitzer Prize), the story of a young medical researcher. Martin Arrowsmith, the protagonist, served as a role model for scores of medical students intent on devoting their lives to medical science. The portra...
I am sitting in an auditorium at Georgetown University attending a symposium on the influence of the pharmaceutical industry on scientific publications and continuing medical education. This is a decidedly hostile crowd. The crusaders are all here, including Arnold Relman, MD, professor ...